EQT Acquires Minority Stake in SHL Medical

January 3, 2020

EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.

Buyers
EQT (EQT VIII Fund)
Targets
SHL Medical
Industry
Medical Devices
Location
Switzerland
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.